Navigation Links
Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
Date:9/25/2008

LAUSANNE, Switzerland, September 25 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, announces the filing of an application with the European Agencies for the approval of its new 6-month formulation of Decapeptyl(R) (triptorelin pamoate 22.5 mg), a luteinizing hormone releasing hormone (LHRH) agonist for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer. Once approved, Decapeptyl(R) 6-month formulation will be marketed by Debiopharm's partners, such as Ipsen in most European Union countries.

"This submission in Europe of our first 6-month-formulation for the treatment of prostate cancer is another demonstration of Debiopharm's commitment to supporting and enhancing the life of cancer patients. With an injection every 24 weeks, patients will benefit from increased convenience and comfort," said Kamel Besseghir, CEO of Debiopharm S.A. "Furthermore, upon approval, our newly built production line will be ready to manufacture the drug for worldwide distribution."

The MAA for Decapeptyl(R) 6 month formulation is supported by data from a phase III study on the efficacy and safety of two consecutive injections of triptorelin 6-month formulation in 120 patients with advanced prostate cancer. The results showed that 97.5% of patients achieved castrate levels of serum testosterone 28 days after the first injection and that 93% of the patients maintained serum testosterone levels below castrate level (defined as < 1.735 nmol/L or 50 ng/dL) from week 8 to 48. These efficacy results are similar to those obtained previously with repeated administrations of the 1- and 3-month formulations of triptorelin.

About Decapeptyl(R)

Triptorelin was licensed-in from Tulane University in 1982. Debiopharm developed and submitted a 1- and 3-month sustained release formulation of triptorelin pamoate in Europe and
'/>"/>

SOURCE Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
2. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
3. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
4. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
5. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
6. CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI
7. Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
8. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
9. ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
10. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
11. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- 3D Communications announced today that ... pharmaceutical companies communicate the value of their drugs ... newly expanded 3D Market Access and Reimbursement ... develop and deliver their "Value Story". It will also ... stakeholders earlier in the "innovation-to-market" timeline, and incorporate ...
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
(Date:5/6/2015)... Advanced wound care - assess products, developments, ... future hold for the advanced wound care ... potential revenues to 2025, assessing data, trends, opportunities and ... provides 115 tables, charts, and graphs covering 12 distinct ... industry and the future market prospects. You will see ...
Breaking Medicine Technology:3D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
(Date:5/7/2015)... 2015 When people think about protecting their ... their roofs than their basements. However, heavy rain falls also ... and basements. While flooding is an obvious problem in a ... unfinished areas dry to avoid a musty smell . ... Even small amounts of water can cause foundation damage, mold ...
(Date:5/7/2015)... Boston, MA (PRWEB) May 07, 2015 ... today the availability of its new free Alcohol ... is aimed at helping restaurant managers, professional bartenders, and ... earn their Alcohol Safety Certification. The material encompasses topics ... Upon completing the course, students can take the ServSafe ...
(Date:5/7/2015)... 07, 2015 “ Sky Hollywood Slots ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... casino game that focuses on slots. , According to the ... traveled to Sin City in 2014. But what’s even more ...
(Date:5/7/2015)... Made with love at the Belvoir ... Vegan, no preservatives, no sweeteners or artificial colors and ... will delight every palate. , Belvoir Fruit Farms launched ... has grown successfully ever since. This range of refreshing ... opportunities as cocktail mixers. , Belvoir is available in ...
(Date:5/6/2015)... A poker run to raise funds for the 2015 National ... run will start at the United Veterans Club, 1914 W. Capital ... poker run, participants will visit checkpoints, drawing a card at each ... the end of the run. The run will start at the ... Tavern, Fairmont American Legion, Hastings DAV post, Kearney American Legion and ...
Breaking Medicine News(10 mins):Health News:Spring Storms Bring Musty Smell Inside 2Health News:Spring Storms Bring Musty Smell Inside 3Health News:Dynamic Path Adds Alcohol Safety Exam Prep Module to Test Preparation Offerings 2Health News:A Social Casino Game that Focuses on Slots Was Featured on NewsWatch Television 2Health News:Updated Contacts: Poker Run Fundraiser to Benefit National Veterans Golden Age Games 2
... This release is available in French . ... two can be spontaneously aggressive and that boys can be ... of boys will continue to be hyper-aggressive until the age ... sub-group of aggressive children has a different makeup than non-aggressive ...
... Inexpensive, well-established lab tests may hold the key ... which is the focus of World Kidney Day, March ... results in kidney failure, cardiovascular disease and anemia. ... percent over the past 10 years. But kidney disease ...
... others involved in tumor development , , TUESDAY, March 10 (HealthDay ... lower risk of developing pancreatic cancer, a finding that might ... , The study, by researchers at the Dana-Farber Cancer ... type and the disease, which is diagnosed in about 40,000 ...
... to Mount For Strawberry Nutrition BenefitsWATSONVILLE, Calif., March 10 ... of super foods that improve health and ... on time. A new study published in the scientific ... in strawberries help lower "bad" cholesterol.The study, conducted by ...
... technology programs implemented in New York state are active ... and could serve as models for new federal initiatives, ... Medical College. , "Programs such as these could transform ... says senior author Dr. Rainu Kaushal, chief of the ...
... Fee Offers Easy, Practical Strategies to Sleep Like a ... More...NEW YORK, March 10 Founder and CEO of ... announced her latest crusade -- educating people about the ... how to achieve high-quality sleep through her revolutionary wellness ...
Cached Medicine News:Health News:Perinatal environment influences aggression in children 2Health News:Upcoming World Kidney Day Underscores Role of Low-Cost Lab Tests in Combating High-Cost Kidney Disease 2Health News:Study Links Blood Type and Pancreatic Cancer 2Health News:Spoonfuls of Strawberries Help the Cholesterol Go Down 2Health News:Spoonfuls of Strawberries Help the Cholesterol Go Down 3Health News:New York State health IT strategy may be model for the nation 2Health News:New York State health IT strategy may be model for the nation 3Health News:Tired? Sleepless? ... New Sleep Program 'Good Night, Sleep Right(TM)' Launches in April 2009 2
Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle....
... CSV- lOOOHGT instrument provides standardized glare testing. It ... test faces for the evaluation of glare disability. ... precisely calibrated to simulate two on-coming halogen car ... The glare level can be adjusted to simulate ...
Designed to determine the precise length of limbal incisions and proper alignment of closing sutures. Curved marking blade with 2 mm lines spaced 1 mm apart-measures up to 10 mm. Round knurled handle...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: